Sector

Healthcare

Region

AUM

678.45M

Fund Score

iShares U.S. Pharmaceutical ETF (ARCA:IHE) Quotes, Forecast and News Summary

iShares U.S. Pharmaceutical ETF (ARCA: IHE) stock price, news, charts, stock research, profile.

Open	$69.55
High	$70.35
52 Wk High	$72.94
AUM	678.45M
Dividend	$1.88
Ex-Div Date	Jun 11, 2024
Volume	16.15K
Market Cap	$229.77B
Mgmt Fee	0.39%
P/E Ratio	19.62
Prev. Close	$69.51
Low	$69.41
52 Wk Low	$56.03
Shares Out	10.15M
Yield	2.70%
Div. Freq	Quarterly
Avg. Volume Daily	63.21K
Beta	0.66
Avg. Expense Ratio	0.39%
P/B Ratio	3.07

Recent News

Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.

Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease.

Shivdeep Dhaliwal

Pharma ETFs in Focus Post Solid Q2 Earnings

The second-quarter results of the healthcare sector have been impressive, with earnings of 78.8% of the sector participants that have reported so far up 17.1% on 7.6% revenue growth. The earnings beat ratio of 85.7% and the revenue beat ratio of 75.5% are also assuring.

Zacks

A Look at Pharma ETFs Post Q1 Earnings

The first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of the sector participants that have reported so far down 31.2% despite 4.4% revenue growth. The earnings beat ratio of 93.9% and the revenue beat ratio of 75.8% are assuring, though.

Zacks

FAQ

How do I buy iShares U.S. Pharmaceutical ETF (IHE) stock?

You can purchase shares of iShares U.S. Pharmaceutical ETF (ARCA:IHE) through any online brokerage.

View our list of the best stock brokerages

Who are iShares U.S. Pharmaceutical ETF (IHE) competitors?

There are no as such competitors for iShares U.S. Pharmaceutical ETF.

What is the forecast, or price target, for iShares U.S. Pharmaceutical ETF (IHE) stock?

There is no analysis for iShares U.S. Pharmaceutical ETF to provide a consensus price target.

What is the current price for iShares U.S. Pharmaceutical ETF (IHE)?

The stock price for iShares U.S. Pharmaceutical ETF (ARCA: IHE) is $70.0046 last updated November 8, 2024 at 8:00 PM EST.

Does iShares U.S. Pharmaceutical ETF (IHE) pay a dividend?

A quarterly cash dividend of 0.35 per share of Class A Common Stock. The quarterly cash dividend was payable on December 21, 2018 to stockholders of record on December 17, 2018.

When is iShares U.S. Pharmaceutical ETF (ARCA:IHE) reporting earnings?

iShares U.S. Pharmaceutical ETF does not have any upcoming earnings scheduled.

Is iShares U.S. Pharmaceutical ETF (IHE) going to split?

There is no upcoming split for iShares U.S. Pharmaceutical ETF.

Open	$69.55
High	$70.35
52 Wk High	$72.94
AUM	678.45M
Dividend	$1.88
Ex-Div Date	Jun 11, 2024
Volume	16.15K
Market Cap	$229.77B
Mgmt Fee	0.39%
P/E Ratio	19.62
Prev. Close	$69.51
Low	$69.41
52 Wk Low	$56.03
Shares Out	10.15M
Yield	2.70%
Div. Freq	Quarterly
Avg. Volume Daily	63.21K
Beta	0.66
Avg. Expense Ratio	0.39%
P/B Ratio	3.07

ETF Details

Sector	Healthcare
Category	High Performer-High Growth
Investment Style	Large Cap Blend
Fund Inception	May 1, 2006
Managers	Paul Whitehead Jennifer Hsui Greg Savage Amy Whitelaw
Definition	A Equity Fund portfolio full of stocks with both strong financial performance and superior growth potential

Investment Policy

The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

Top ETF Holdings

Symbol	Name	Share %
JNJ	Johnson & Johnson	23.8%
LLY	Eli Lilly & Co.	20.3%
VTRS	Viatris	4.97%
BMY	Bristol-Myers Squibb C...	4.91%
PFE	Pfizer, Inc.	4.84%
ZTS	Zoetis Inc. [zts]	4.49%
RPRX	Royalty Pharma	4.35%
CTLT	Catalent, Inc.	4.27%
MRK	Merck & Company Inc.	3.81%
ITCI	Intra-Cellular Therapi...	3.08%

Comments

iShares U.S. Pharmaceutical ETF

Overview